Back to Insights

GoAI Market Wrap - 2nd Apr

Go Wire
Go Wire
April 2, 2026
GoGPT Summarizes Articles

On Wednesday in U.S. Eastern Time, all three major U.S. stock indices closed higher as President Trump hinted that the Middle East conflict may be nearing its end, boosting risk appetite.

Daily Market Brief  ·  Thursday, April 2, 2026
U.S. Market Close
DJIA46,565.86▲ 0.48%
S&P 5006,575.36▲ 0.72%
NASDAQ21,840.95▲ 1.16%
As of April 1 Close
GoAI Sentiment Index
Score: 17 — Fear
The dominant force is the war itself: the Strait of Hormuz remains effectively shut, Brent crude hovers just above $100, and consumers are buckling under $4/gallon gas. But here’s what’s interesting — credit markets aren’t panicking.
Key Headlines
TECHNOLOGY
SpaceX Said to Have Filed IPO Application
HEALTHCARE
Eli Lilly’s Blockbuster Oral Weight-Loss Drug Approved for Market
TECHNOLOGY
OpenAI Shares Stall in Secondary Market as Demand Shifts to Anthropic
Market Analysis
Global Market Indices Update - April 2, 2026
All three major U.S. indices closed higher on Wednesday as President Trump hinted that the Middle East conflict may be nearing its end, boosting risk appetite. Trump stated that U.S. military action had left Iran unable to develop nuclear weapons, and that American forces would soon withdraw — though targeted strikes remain an option if necessary. He was set to address the nation on the Iran war later that evening with a significant update on the situation.

Thomas Martin, Senior Portfolio Manager at Globalt Investments, noted: “Trump’s statements tend to shift frequently. The market is trying to read his true intentions. Investors want to hear positive signals — they want the war to end.”

U.S. stocks rose for a second consecutive session as investors bet that military operations against Iran could soon conclude. Over the past month, the conflict had severely disrupted oil flows through the Strait of Hormuz, sending energy prices sharply higher and stoking global inflation fears.

Markets had already been lifted by earlier “fragile optimism,” including reports that Iranian President Pezeshkian signaled Iran’s willingness to end the war if certain conditions — such as guarantees against future attacks — were met. Thomas Mathews, Head of Asia-Pacific Markets at Capital Economics, wrote: “Hopes of de-escalation have boosted markets, but even if the war ends quickly, its effects will linger in many ways.” He added: “If sentiment continues to improve, is there further upside? The answer is almost certainly yes.”

However, the risk of escalation remains significant. Without a clear end announcement, near-term volatility is likely to persist.
Key Events
SpaceX Said to Have Filed IPO Application
Elon Musk’s SpaceX has reportedly submitted a confidential IPO filing to the SEC — a pivotal step toward what could become the largest public offering in history. Sources indicate the rocket and satellite company is targeting a raise of $40–$80 billion, with a potential valuation of up to $1.75 trillion. The filing puts SpaceX on track for a possible listing as early as July, consistent with timelines Musk has previously shared with insiders.
OpenAI Shares Stall in Secondary Market as Demand Shifts to Anthropic
Ken Smythe, founder of secondary market platform NextRound Capital, told media on Wednesday that demand for OpenAI shares on their platform is declining. Several hedge funds and venture capital firms holding large positions have approached the platform seeking to offload approximately $600 million in OpenAI stock — but found no takers among hundreds of institutional investors. Meanwhile, Augment co-founder Adam Crawley noted that the valuation gap between OpenAI ($852B) and Anthropic ($380B) is driving investors to aggressively pursue Anthropic shares instead.
Eli Lilly’s Blockbuster Oral Weight-Loss Drug Approved for Market
Eli Lilly announced Wednesday that the FDA has approved its GLP-1 oral drug Foundayo (orforglipron) for commercial use — a landmark milestone for the company and a major test of the oral weight-loss drug market. Lilly shares closed up 3.78% on the news. The once-daily pill will begin shipping via its direct platform LillyDirect next Monday, with broader pharmacy and telehealth availability to follow shortly. Pricing starts at $25/month for insured patients using a coupon, and $149–$349/month for self-pay patients depending on dosage.
Commodities
NYMEX WTI Crude▼ 1.24%
ICE Brent Crude▼ 2.70%
COMEX Gold▲ 2.27%
COMEX Silver▲ 0.38%
NYMEX Natural Gas▼ 2.50%
LME Copper▲ 0.73%
LME Aluminum▲ 2.66%
LME Zinc▲ 2.16%
LME Tin▲ 0.96%
LME Nickel▲ 0.52%
Forex
EUR/USD1.1607▲ 0.73%
GBP/USD1.3324▲ 1.02%
USD/JPY158.82▼ 0.08%
USD/CNY6.8942▼ 0.25%
Key Event: U.S. ISM Manufacturing PMI beat expectations at 52.7 in March, with the prices-paid component surging to 78.3 — signaling persistent inflation pressures and complicating the Fed’s rate outlook. The dollar weakened broadly on de-escalation optimism; USD/JPY edged slightly lower as yen safe-haven demand eased.
Sector Intelligence
HEALTHCARE & FINANCIALS
LLY (Eli Lilly)$868.20▲ 3.78%
XLF (Financials)$49.44▲ 0.14%
Key Drivers: LLY surged 3.78% after FDA approved Foundayo (orforglipron), Eli Lilly’s once-daily oral GLP-1 drug — a landmark for the weight-loss market. Financials (XLF +0.14%) were broadly flat as rate expectations remained mixed. Energy (XLE −3.74%) led sector declines on ceasefire optimism compressing crude’s geopolitical premium.
SHIPPING & LOGISTICS
Freightos Baltic Index (FBX)$1,760
Baltic Dry Index2,030
Market Dynamics: BDI rebounded 1.75% to 2,030, led by capesize gains, snapping a two-day slide. FBX eased to ~$1,760/FEU as Asia–Europe container rates stabilized. A confirmed Hormuz reopening remains the key variable — it would sharply compress the geopolitical premium in both tanker and container rates.
Institutional Views
GoAIBEARISH
The two-day rally is geopolitically driven — the Strait of Hormuz remains closed and macro risks are intact. Trump’s national address is the next binary: a formal ceasefire would extend the rally; any ambiguity risks a sharp reversal.
Goldman SachsNEUTRAL
Goldman Sachs maintains a cautiously constructive stance after two consecutive days of gains, but flags the rally as “event-driven and fragile.” The bank keeps its recession probability at 25% and reiterates its bear-case S&P 500 target of 5,400 if Hormuz remains closed beyond April. It recommends trimming energy overweights and rotating toward quality growth.
Morgan StanleyBULLISH
Mike Wilson says the two-day rally confirms the selloff was geopolitical, not fundamental. With S&P 500 back above 6,500 and 2026 EPS growth of 12% intact, Morgan Stanley reiterates its year-end target of 7,400. It recommends adding to healthcare and semiconductors ahead of Trump’s national address on Iran.
Digital Assets (24h)
Bitcoin (BTC)$68,220.16▲ 0.49%
Ethereum (ETH)$2,138.51▲ 1.93%
XRP$1.34▲ 0.66%
Solana (SOL)$81.09▼ 2.43%
GoAI Performance
Today’s Live P&L
SPY (Benchmark)▲ 0.75%
GoAI Portfolio▲ 0.92%
Alpha vs SPY▲ 0.17%
Positions68 / 68
Performance Metrics
Total Return (TWR, YTD)▲ 26.94%
Win Rate (38/68)55.9%
Our AI-driven approach combines real-time sentiment analysis with fundamental rigor to identify high-conviction opportunities.
 
#Market Morning Wrap